NURP 424 Pharm Exam 1 2025/2026
Exam Questions with 100% Correct
Answers | Latest Update
Considerations when prescribing: - 🧠 ANSWER ✔✔I: Indication
C: contraindication
P: precautions or interactions
C: cost/compliance
E: efficacy
A: adverse effects
D: dose/duration/directions
Drug approval process: Phase I - 🧠 ANSWER ✔✔Phase I: safety and safe
dosage- how the drug is tolerated at different doses- does not determine
efficacy; studies the pharmacokinetics of the drug
(After the preclinical animal testing phase)
1
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
,Drug Approval Process: Phase II - 🧠 ANSWER ✔✔Phase II: determine
dosage and efficacy; determine short-term risks
Drug Approval Process: Phase III - 🧠 ANSWER ✔✔Phase III: controlled
and uncontrolled clinical trials of safety and efficacy in multiple settings;
submit a new drug application (NDA) to the FDA
-Is it better than current treatment?
Drug Approval Process: Post Market - 🧠 ANSWER ✔✔Phase IV or Post
market research: has no fixed duration, further report adverse events
DEA Controlled Drug Schedules: Schedule 1 - 🧠 ANSWER ✔✔- No
accepted medical use
-No legal use permitted
- For registered research facilities only
Heroin, LSD, mescaline, peyote, marijuana*(state to state)
DEA Controlled Drug Schedules: Schedule 2 - 🧠 ANSWER ✔✔-No refills
permitted (only 30 day supply)
-No phone orders unless you have a written one within 7 days
-E-prescribe is OK
2
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
,- expires in 72hrs id not filled
Narcotics, stimulants, depressants (phenobarbital, secobarbital)
DEA Controlled Drug Schedules: Schedule 3 - 🧠 ANSWER ✔✔-must be
rewritten after 6 months or five refills
-phone and fax OK
Some narcotics (Percocet, hydrocodone) Some stimulants
(benzphetamine, chlorpheniramine, diethylpropion)
Anabolic steroids, testosterone
DEA Controlled Drug Schedules: Schedule 4 - 🧠 ANSWER ✔✔-same as
schedule 3, penalties for illegal possessions are different
-low potential for abuse per DEA
pentazocine, phentermine, benzos, meprobamate
DEA Controlled Drug Schedules: Schedule 5 - 🧠 ANSWER ✔✔- same as
all prescription drugs
-may be dispensed without prescription unless regulated by the state
loperamide, cough meds, pregabalin
3
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
, Adverse Drug Reactions: Pharmacological - 🧠 ANSWER ✔✔- majority of
adverse reactions
-predictable
-dose-related
-85-90% of ADRs
(Hypotension from antihypertensives)
Adverse Drug Reactions: Idiosyncratic - 🧠 ANSWER ✔✔-unpredictable
-Not dose-related
(Stevens-Johnson syndrome from lamictal or ibuprofen)
Immune-Mediated ADR: Type 1 - 🧠 ANSWER ✔✔-igE mediated, immediate
type
-previously sensitize person
-hypersensitivity like atopic dermatitis, hives, angioedema or anaphylaxis
Immune-Mediated ADR: Type 2 - 🧠 ANSWER ✔✔- antibody-dependent
cytotoxicity
- "autoimmune response"
4
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
Exam Questions with 100% Correct
Answers | Latest Update
Considerations when prescribing: - 🧠 ANSWER ✔✔I: Indication
C: contraindication
P: precautions or interactions
C: cost/compliance
E: efficacy
A: adverse effects
D: dose/duration/directions
Drug approval process: Phase I - 🧠 ANSWER ✔✔Phase I: safety and safe
dosage- how the drug is tolerated at different doses- does not determine
efficacy; studies the pharmacokinetics of the drug
(After the preclinical animal testing phase)
1
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
,Drug Approval Process: Phase II - 🧠 ANSWER ✔✔Phase II: determine
dosage and efficacy; determine short-term risks
Drug Approval Process: Phase III - 🧠 ANSWER ✔✔Phase III: controlled
and uncontrolled clinical trials of safety and efficacy in multiple settings;
submit a new drug application (NDA) to the FDA
-Is it better than current treatment?
Drug Approval Process: Post Market - 🧠 ANSWER ✔✔Phase IV or Post
market research: has no fixed duration, further report adverse events
DEA Controlled Drug Schedules: Schedule 1 - 🧠 ANSWER ✔✔- No
accepted medical use
-No legal use permitted
- For registered research facilities only
Heroin, LSD, mescaline, peyote, marijuana*(state to state)
DEA Controlled Drug Schedules: Schedule 2 - 🧠 ANSWER ✔✔-No refills
permitted (only 30 day supply)
-No phone orders unless you have a written one within 7 days
-E-prescribe is OK
2
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
,- expires in 72hrs id not filled
Narcotics, stimulants, depressants (phenobarbital, secobarbital)
DEA Controlled Drug Schedules: Schedule 3 - 🧠 ANSWER ✔✔-must be
rewritten after 6 months or five refills
-phone and fax OK
Some narcotics (Percocet, hydrocodone) Some stimulants
(benzphetamine, chlorpheniramine, diethylpropion)
Anabolic steroids, testosterone
DEA Controlled Drug Schedules: Schedule 4 - 🧠 ANSWER ✔✔-same as
schedule 3, penalties for illegal possessions are different
-low potential for abuse per DEA
pentazocine, phentermine, benzos, meprobamate
DEA Controlled Drug Schedules: Schedule 5 - 🧠 ANSWER ✔✔- same as
all prescription drugs
-may be dispensed without prescription unless regulated by the state
loperamide, cough meds, pregabalin
3
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
, Adverse Drug Reactions: Pharmacological - 🧠 ANSWER ✔✔- majority of
adverse reactions
-predictable
-dose-related
-85-90% of ADRs
(Hypotension from antihypertensives)
Adverse Drug Reactions: Idiosyncratic - 🧠 ANSWER ✔✔-unpredictable
-Not dose-related
(Stevens-Johnson syndrome from lamictal or ibuprofen)
Immune-Mediated ADR: Type 1 - 🧠 ANSWER ✔✔-igE mediated, immediate
type
-previously sensitize person
-hypersensitivity like atopic dermatitis, hives, angioedema or anaphylaxis
Immune-Mediated ADR: Type 2 - 🧠 ANSWER ✔✔- antibody-dependent
cytotoxicity
- "autoimmune response"
4
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
